Literature DB >> 4336566

Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein-Barr virus infection.

M Nonoyama, J S Pagano.   

Abstract

Infection of Raji cells with Epstein-Barr virus (EBV) causes suppression of cellular deoxyribonucleic acid (DNA) synthesis and fragmentation of the cellular DNA. About 1,000 copies of EBV DNA of normal size (about 5 x 10(7) daltons in a single strand, as shown in an alkaline gradient) are synthesized per cell.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4336566      PMCID： PMC356360     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  6 in total

1.  Detection of Epstein-Barr viral genome in nonproductive cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1971-09-22

2.  Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus.

Authors:  P Gerber; B H Hoyer
Journal:  Nature       Date:  1971-05-07       Impact factor: 49.962

3.  Host cell macromolecular synthesis in cells containing EBV-induced early antigens, studied by combined immunofluorescence and radioautography.

Authors:  L Gergely; G Klein; I Ernberg
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

4.  Size, composition, and structure of the deoxyribonucleic acid of herpes simplex virus subtypes 1 and 2.

Authors:  E D Kieff; S L Bachenheimer; B Roizman
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

5.  Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures.

Authors:  P Gerper; J Whang-Peng; J H Monroe
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

6.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728
  6 in total
  17 in total

1.  Effects of adenine arabinoside on lymphocytes infected with Epstein-Barr virus.

Authors:  W C Benz; P J Siegel; J Baer
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

2.  Viral and cellular DNA synthesis in nuclei from human lymphocytes transformed by Epstein-Barr virus.

Authors:  W C Benz; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

3.  Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.

Authors:  Y Yajima; M Nonoyama
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

4.  Characterization of sublines of Epstein-Barr virus producing HR-1 cells and its implication in virus propagation in culture.

Authors:  G Q Yao; C H Tsai; Y C Cheng
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

5.  Epstein-Barr virus-associated thymidine kinase.

Authors:  S T Chen; J E Estes; E S Huang; J S Pagano
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

6.  Radiobiological inactivation of Epstein-Barr virus.

Authors:  E Henderson; L Heston; E Grogan; G Miller
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

7.  Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.

Authors:  J E Shaw; L F Levinger; C W Carter
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

8.  Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.

Authors:  J C Lin; M C Smith; J S Pagano
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  Human cytomegalovirus genome: partial denaturation map and organization of genome sequences.

Authors:  B A Kilpatrick; E S Huang
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

10.  Epstein-Barr virus induces fragmentation of chromosomal DNA during lytic infection.

Authors:  M Kawanishi
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.